CCT2 and cancer: Low levels of HSP90AB1/TRAP1, HSPA6/TRAP1, and HSP90AA1/TRAP1 in urine increase the probability of the patient having cancer, whereas low levels of CCT2/HSP90AB1 and HSPB1*HSPA9 in urine are strongly associated with non-cancer groups (Figure 1C).